Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
AILERON THERAPEUTICS INC | Director | Stock Option (right to buy) | 54.5K | Jun 15, 2022 | Direct | ||
Aurinia Pharmaceuticals Inc. | Director | Stock Option (right to buy) | 29K | Aug 18, 2023 | Direct | ||
Aurinia Pharmaceuticals Inc. | Director | Restricted Stock Units | 17.9K | Aug 18, 2023 | Direct | ||
BIODELIVERY SCIENCES INTERNATIONAL INC | Chief Executive Officer, Director | Common Stock | 0 | $1.80 | Mar 22, 2022 | Direct | |
BIODELIVERY SCIENCES INTERNATIONAL INC | Chief Executive Officer, Director | Restricted Stock Units | 0 | Mar 22, 2022 | Direct | ||
BIODELIVERY SCIENCES INTERNATIONAL INC | Chief Executive Officer, Director | Stock Options (right to buy) | 0 | $2.93 | Mar 22, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
AUPH | Aurinia Pharmaceuticals Inc. | Aug 18, 2023 | 2 | $0 | 4 | Aug 21, 2023 | Director |
AUPH | Aurinia Pharmaceuticals Inc. | Aug 18, 2023 | 0 | $0 | 3 | Aug 21, 2023 | Director |
BDSI | BIODELIVERY SCIENCES INTERNATIONAL INC | Mar 22, 2022 | 7 | $0 | 4 | Mar 22, 2022 | Chief Executive Officer, Director |
BDSI | BIODELIVERY SCIENCES INTERNATIONAL INC | Mar 9, 2022 | 2 | $0 | 4 | Mar 11, 2022 | Chief Executive Officer, Director |
BDSI | BIODELIVERY SCIENCES INTERNATIONAL INC | Jan 27, 2022 | 2 | $4.19M | 4 | Jan 31, 2022 | Chief Executive Officer, Director |
BDSI | BIODELIVERY SCIENCES INTERNATIONAL INC | Nov 4, 2021 | 2 | $0 | 4 | Nov 8, 2021 | Chief Executive Officer, Director |
BDSI | BIODELIVERY SCIENCES INTERNATIONAL INC | Aug 6, 2021 | 2 | $0 | 4 | Aug 10, 2021 | Chief Executive Officer, Director |
ALRN | AILERON THERAPEUTICS INC | Jun 15, 2021 | 1 | $0 | 4 | Jun 17, 2021 | Director |
ALRN | AILERON THERAPEUTICS INC | Jun 15, 2020 | 1 | $0 | 4 | Jun 17, 2022 | Director |